Company intelligence / Profile preview
Inventage Lab
- Ownership
- Private
- Development stage
- Other
Overview
Inventage Lab has developed proprietary microfluidics-driven platforms for the design and scalable manufacturing of long-lasting injectable drugs. Their pipeline includes both human and veterinary medicines targeting chronic and incurable diseases. Clinical results have not been detailed publicly but the company claims fully developed in-house technology from design to process optimization. Some products may be at or near clinical trial stages while others are in preclinical development or commercialized as veterinary drugs.
- Therapeutic areas
- ImmunologyDermatologyOncologyNeurologyInfectious Diseases
- Modalities
- Microsphere-based long-acting injectablesLipid Nanoparticles (LNPs)Antibody/mRNA-based gene therapy
- Industry
- Biotech
Drug pipeline
12 assets11 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Inventage Lab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inventage Lab.